A digital musculoskeletal platform founded by an ex-Premier League physiotherapist is aiming for a wider Scottish rollout after a successful debut in the Highlands.

The Phio platform has been used by the local health and social care partnership in the region to help people with joint or muscular problems to better self-manage their conditions.

NHS Highland, who were the first to launch a MSK digital provision in primary care in Scotland in December 2023, have released data to show successful integration of Phio into primary care since then, demonstrating the tangible benefits of digital innovation in the NHS and paving the way for wider adoption across the country. 

MSK issues represent one of the largest healthcare burdens worldwide, with approximately 20-30% of the population requiring support for MSK-related injuries. In Scotland, significant pressures on primary and community care have led to extensive need for routine physiotherapy appointments and long waiting lists. Recognising the need for scalable and efficient solutions, Highland HSCP deployed Phio Access and Phio Engage in 2023 to create a digital front door for MSK support.

Co-founded by ex-Premier League Physiotherapist, Pete Grinbergs, Phio Access is designed to assess a patient’s suitability for self-management covering all areas of the body, while Phio Engage provides a clinically supported digital MSK pathway as an alternative to traditional face-to-face care.

According to the company, the platform has reached:

  • 250,000 patients in the region are eligible to access Phio.
  • 2,100 patients have used Phio within the first 12 months.
  • 75% of assessed patients qualify for and consent to self-management instead of face-to-face care.

The deployment has already resulted in significant efficiency gains, including:

  • 3,200 primary care consultations saved annually
  • 480 community physiotherapy appointments freed up each year

Jude Arnaud, clinical lead for first contact physiotherapists at NHS Highland HSCP, said: “The impact of Phio at Highland HSCP has been significant, with both clinicians and patients providing overwhelmingly positive feedback. Phio technology enhances our ability to deliver high-quality care while also empowering patients to take an active role in managing their musculoskeletal health. By streamlining access to support and self-management tools, Phio is helping to improve outcomes and reduce pressure on NHS services simultaneously.”

Jason Ward, co-founder and CEO at EQL, said: “Scotland’s success with Phio serves as a benchmark for digital health adoption across the UK. With strong ROI data demonstrating cost savings growing from £2.00 per £1 invested in Year 1 to £2.33 by Year 3, the case for wider implementation is clear. Digital health is no longer a future ambition, it is happening now, with real impact. We will continue to work with our NHS partners in Scotland to evaluate Phio, as well as push forward our plans for wider NHS adoption across the UK.”